Vosaroxin Hydrochloride is a selective topoisomerase II inhibitor utilized in the treatment of adult patients with metastatic castration-resistant prostate cancer. By inhibiting the type II topoisomerase… Read more
Vosaroxin Hydrochloride is a selective topoisomerase II inhibitor utilized in the treatment of adult patients with metastatic castration-resistant prostate cancer. By inhibiting the type II topoisomerase enzyme, this agent induces site-selective DNA damage that effectively prevents DNA replication and transcription within malignant cells. To support the rigorous demands of pharmaceutical development, this category offers high-quality reference standards for the active pharmaceutical ingredient, alongside its known impurities, metabolites, and stable isotope-labelled compounds. These critical materials are essential for pharmaceutical laboratories conducting analytical testing, impurity profiling, and method validation to ensure regulatory compliance. By incorporating precise analytical standards and isotopically labelled internal standards, researchers can achieve the accuracy required for method development, stability testing, and the precise quantification of trace-level impurities during the quality control process.